Skip to main content

Table 1 Patient demographics and summary of fusion-guided biopsy findings

From: Assessment of free-hand transperineal targeted prostate biopsy using multiparametric magnetic resonance imaging-transrectal ultrasound fusion in Chinese men with prior negative biopsy and elevated prostate-specific antigen

Ā 

All patients

Men with PCa

Prostatectomy cohort

Men, no.

101

41 (40.6)

26 (25.7)

Age, year

68.9ā€‰Ā±ā€‰8.1

67.8ā€‰Ā±ā€‰8.0

65.2ā€‰Ā±ā€‰7.2

PSA, ng/ml

10.8ā€‰Ā±ā€‰6.1

11.3ā€‰Ā±ā€‰6.3

11.2ā€‰Ā±ā€‰6.3

Prostate volume, ml

42.1ā€‰Ā±ā€‰15.3

39.4ā€‰Ā±ā€‰13.6

35.1ā€‰Ā±ā€‰11.8

Prior negative biopsy, no.

1.5ā€‰Ā±ā€‰0.7

1.4ā€‰Ā±ā€‰0.6

1.4ā€‰Ā±ā€‰0.6

MRI lesions per patient, no.

1.9ā€‰Ā±ā€‰1.0

2.1ā€‰Ā±ā€‰1.1

2.4ā€‰Ā±ā€‰1.0

PI-RAD score, no. (%)

ā€ƒ2

13 (12.9)

1 (1.0)

0 (0)

ā€ƒ3

31 (30.7)

3 (3.0)

0 (0)

ā€ƒ4

36 (35.6)

19 (18.8)

12 (11.9)

ā€ƒ5

21 (20.8)

18 (17.8)

14 (13.9)

TB cores per patiens

4.2ā€‰Ā±ā€‰1.5

4.8ā€‰Ā±ā€‰1.6

4.9ā€‰Ā±ā€‰1.8

Insignificant PCa

-

16 (15.8)

6 (5.9)

Significant PCa

-

25 (24.8)

20 (19.8)

Gleason score, no. (%)

ā€ƒGleason 6

-

17 (16.8)

6 (5.9)

ā€ƒGleason 7 (3Ā +Ā 4)

-

9 (8.9)

8 (7.9)

ā€ƒGleason 7 (4Ā +Ā 3)

-

7 (6.9)

5 (5.0)

ā€ƒGleason ā‰„8

-

8 (7.9)

7 (6.9)

  1. Continuous variables reported as meanā€‰Ā±ā€‰standard deviation
  2. PSA prostate-specific antigen, MRI magnetic resonance imaging, PCa prostate cancer, SB systematic biopsy, TB targeted biopsy